FI962969A0 - Indolijohdannaisia 5-HT1:n agonisteina - Google Patents
Indolijohdannaisia 5-HT1:n agonisteinaInfo
- Publication number
- FI962969A0 FI962969A0 FI962969A FI962969A FI962969A0 FI 962969 A0 FI962969 A0 FI 962969A0 FI 962969 A FI962969 A FI 962969A FI 962969 A FI962969 A FI 962969A FI 962969 A0 FI962969 A0 FI 962969A0
- Authority
- FI
- Finland
- Prior art keywords
- agonists
- indole derivatives
- indole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9401436A GB9401436D0 (en) | 1994-01-26 | 1994-01-26 | Therapeutic heterocyclic compounds |
| PCT/GB1995/000142 WO1995020588A1 (en) | 1994-01-26 | 1995-01-25 | Indole derivatives as 5-ht1 agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI962969A FI962969A (fi) | 1996-07-25 |
| FI962969A0 true FI962969A0 (fi) | 1996-07-25 |
Family
ID=10749321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI962969A FI962969A0 (fi) | 1994-01-26 | 1996-07-25 | Indolijohdannaisia 5-HT1:n agonisteina |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US5744466A (fi) |
| EP (1) | EP0741725A1 (fi) |
| JP (1) | JPH09512248A (fi) |
| CN (1) | CN1143960A (fi) |
| AP (1) | AP632A (fi) |
| AU (2) | AU689195B2 (fi) |
| BG (1) | BG100747A (fi) |
| BR (1) | BR9506581A (fi) |
| CA (1) | CA2181475A1 (fi) |
| CZ (1) | CZ216996A3 (fi) |
| EE (1) | EE9600095A (fi) |
| FI (1) | FI962969A0 (fi) |
| GB (1) | GB9401436D0 (fi) |
| HU (1) | HUT76288A (fi) |
| IL (1) | IL112443A (fi) |
| MX (1) | MX9602979A (fi) |
| NO (1) | NO963117L (fi) |
| NZ (1) | NZ278644A (fi) |
| OA (1) | OA10307A (fi) |
| PL (1) | PL315666A1 (fi) |
| SG (1) | SG44926A1 (fi) |
| SK (1) | SK96796A3 (fi) |
| TW (1) | TW377344B (fi) |
| WO (1) | WO1995020588A1 (fi) |
| YU (1) | YU4795A (fi) |
| ZA (1) | ZA95601B (fi) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6376463B1 (en) * | 1992-04-07 | 2002-04-23 | Emory University | Modified factor VIII |
| GB9515060D0 (en) * | 1995-07-22 | 1995-09-20 | Wellcome Found | Therapeutic heterocyclic compounds |
| GB9515305D0 (en) * | 1995-07-26 | 1995-09-20 | Wellcome Found | Therapeutic heterocyclic compounds |
| US6909005B1 (en) | 1995-08-07 | 2005-06-21 | Astrazeneca Uk Limited | One post synthesis of 2-oxazolidinone derivatives |
| GB9516145D0 (en) * | 1995-08-07 | 1995-10-04 | Wellcome Found | Improved chemical synthesis |
| GB9516143D0 (en) * | 1995-08-07 | 1995-10-04 | Wellcome Found | Improved chemical synthesis |
| AU2104097A (en) * | 1996-03-13 | 1997-10-01 | Glaxo Group Limited | Medicaments comprising 5ht1-like receptor agonists with an increased absorption |
| US5654431A (en) * | 1996-05-30 | 1997-08-05 | Meng; Qingchang | 5-alkoxy tryptamine derivatives |
| AU5194999A (en) * | 1998-08-07 | 2000-02-28 | Takeda Chemical Industries Ltd. | Benzothiepin derivatives, process for the preparation of the same and uses thereof |
| CA2390531A1 (en) * | 1999-11-08 | 2001-05-17 | Wyeth | ¬(indol-3-yl)-cycloalkyl|-3-substituted azetidines for the treatment of central nervous system disorders |
| US6245799B1 (en) | 1999-11-08 | 2001-06-12 | American Home Products Corp | [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders |
| EP1268422A1 (de) * | 2000-03-23 | 2003-01-02 | Bayer Aktiengesellschaft | Indole zur behandlung von krankheiten die mit schilddrüsenhormonen behandeln werden können |
| WO2002024631A1 (en) * | 2000-09-18 | 2002-03-28 | Pharmacia & Upjohn Company | Process to prepare (2s)-2-(dipropylamino)-6-ethoxy-2,3-dihydro-1h-indene-5-carboxamide |
| JP2004517851A (ja) | 2000-12-27 | 2004-06-17 | バイエル アクチェンゲゼルシャフト | 甲状腺受容体のリガンドとしてのインドール誘導体 |
| JP4981794B2 (ja) * | 2005-06-03 | 2012-07-25 | アボット・ラボラトリーズ | シクロブチルアミン誘導体 |
| CN103382174A (zh) | 2006-06-23 | 2013-11-06 | 雅培制药有限公司 | 作为组胺h3受体调节物的环丙胺衍生物 |
| US9108948B2 (en) | 2006-06-23 | 2015-08-18 | Abbvie Inc. | Cyclopropyl amine derivatives |
| US9186353B2 (en) | 2009-04-27 | 2015-11-17 | Abbvie Inc. | Treatment of osteoarthritis pain |
| WO2014164467A1 (en) | 2013-03-13 | 2014-10-09 | Bristol-Myers Squibb Company | Inhibitors of human immunodeficiency virus replication |
| WO2021004516A1 (en) * | 2019-07-11 | 2021-01-14 | Ascentage Pharma (Suzhou) Co., Ltd. | Method for preparing 2-indolinospirone compound and intermediate thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8419575D0 (en) * | 1984-08-01 | 1984-09-05 | Glaxo Group Ltd | Chemical compounds |
| GB8724912D0 (en) * | 1987-10-23 | 1987-11-25 | Wellcome Found | Indole derivatives |
| IL92096A0 (en) * | 1988-10-25 | 1990-07-12 | Abbott Lab | Carboxylic nucleoside analogs |
| US4988703A (en) * | 1989-05-22 | 1991-01-29 | Abbott Laboratories | Carbocyclic nucleoside analogs with antiviral activity |
| AU646871B2 (en) * | 1990-06-07 | 1994-03-10 | Astrazeneca Uk Limited | Therapeutic heterocyclic compounds |
| AU672802B2 (en) * | 1992-07-24 | 1996-10-17 | Merck Sharp & Dohme Limited | Imidazole, triazole and tetrazole derivatives |
-
1994
- 1994-01-26 GB GB9401436A patent/GB9401436D0/en active Pending
-
1995
- 1995-01-25 IL IL11244395A patent/IL112443A/en not_active IP Right Cessation
- 1995-01-25 US US08/682,615 patent/US5744466A/en not_active Expired - Lifetime
- 1995-01-25 PL PL95315666A patent/PL315666A1/xx unknown
- 1995-01-25 JP JP7519933A patent/JPH09512248A/ja active Pending
- 1995-01-25 EP EP95906423A patent/EP0741725A1/en not_active Withdrawn
- 1995-01-25 AP APAP/P/1996/000834A patent/AP632A/en active
- 1995-01-25 EE EE9600095A patent/EE9600095A/xx unknown
- 1995-01-25 SK SK967-96A patent/SK96796A3/sk unknown
- 1995-01-25 AU AU14620/95A patent/AU689195B2/en not_active Ceased
- 1995-01-25 ZA ZA95601A patent/ZA95601B/xx unknown
- 1995-01-25 BR BR9506581A patent/BR9506581A/pt not_active Application Discontinuation
- 1995-01-25 CZ CZ962169A patent/CZ216996A3/cs unknown
- 1995-01-25 CA CA002181475A patent/CA2181475A1/en not_active Abandoned
- 1995-01-25 NZ NZ278644A patent/NZ278644A/en unknown
- 1995-01-25 TW TW084100625A patent/TW377344B/zh active
- 1995-01-25 WO PCT/GB1995/000142 patent/WO1995020588A1/en not_active Application Discontinuation
- 1995-01-25 CN CN95192108A patent/CN1143960A/zh active Pending
- 1995-01-25 HU HU9602035A patent/HUT76288A/hu unknown
- 1995-01-25 SG SG1996009484A patent/SG44926A1/en unknown
- 1995-01-26 YU YU4795A patent/YU4795A/sh unknown
-
1996
- 1996-07-22 OA OA60866A patent/OA10307A/en unknown
- 1996-07-24 MX MX9602979A patent/MX9602979A/es unknown
- 1996-07-25 BG BG100747A patent/BG100747A/xx unknown
- 1996-07-25 NO NO963117A patent/NO963117L/no unknown
- 1996-07-25 FI FI962969A patent/FI962969A0/fi unknown
-
1998
- 1998-01-20 US US09/008,833 patent/US5922748A/en not_active Expired - Fee Related
- 1998-04-21 AU AU63489/98A patent/AU6348998A/en not_active Abandoned
-
1999
- 1999-02-23 US US09/255,753 patent/US6103752A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU689195B2 (en) | 1998-03-26 |
| HUT76288A (en) | 1997-07-28 |
| CZ216996A3 (en) | 1997-06-11 |
| SG44926A1 (en) | 1997-12-19 |
| MX9602979A (es) | 1998-01-31 |
| BG100747A (en) | 1997-03-31 |
| IL112443A0 (en) | 1995-03-30 |
| US5744466A (en) | 1998-04-28 |
| AU1462095A (en) | 1995-08-15 |
| GB9401436D0 (en) | 1994-03-23 |
| WO1995020588A1 (en) | 1995-08-03 |
| JPH09512248A (ja) | 1997-12-09 |
| AU6348998A (en) | 1998-06-18 |
| HU9602035D0 (en) | 1996-09-30 |
| OA10307A (en) | 1997-10-07 |
| AP9600834A0 (en) | 1996-07-31 |
| US5922748A (en) | 1999-07-13 |
| EP0741725A1 (en) | 1996-11-13 |
| IL112443A (en) | 1998-12-27 |
| FI962969A (fi) | 1996-07-25 |
| PL315666A1 (en) | 1996-11-25 |
| BR9506581A (pt) | 1997-09-23 |
| AP632A (en) | 1998-03-30 |
| US6103752A (en) | 2000-08-15 |
| YU4795A (sh) | 1998-12-23 |
| SK96796A3 (en) | 1997-06-04 |
| NZ278644A (en) | 1998-02-26 |
| EE9600095A (et) | 1996-12-16 |
| ZA95601B (en) | 1996-07-25 |
| CA2181475A1 (en) | 1995-08-03 |
| CN1143960A (zh) | 1997-02-26 |
| NO963117L (no) | 1996-09-23 |
| NO963117D0 (no) | 1996-07-25 |
| TW377344B (en) | 1999-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI962969A0 (fi) | Indolijohdannaisia 5-HT1:n agonisteina | |
| KR950700906A (ko) | 5-ht1 작동약으로서의 인돌 유도체(indole derivatives as 5-ht1 agonists) | |
| DK0516349T3 (da) | 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister | |
| FI944805A (fi) | Indolijohdannaisia 5-HT1-kaltaisina agonisteina | |
| NO992725L (no) | 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer | |
| FI970310A0 (fi) | 4-indolijohdannaiset serotoniinin vaikuttaja- ja vastavaikuttaja-aineina | |
| DK0393936T3 (da) | 3-substituerede 2-oxindolderivater som antiinflammatoriske midler | |
| MA26542A1 (fr) | Derives oxindole substitues. | |
| NO962232L (no) | 3-substituerte oksindolderivater som kaliumkanalmodulater | |
| DK1001934T3 (da) | Indolforbindelser som COX-2-inhibitorer | |
| NO20003451D0 (no) | 2,3-substituerte indolforbindelser som cox-2 inhibitorer | |
| FI961628A0 (fi) | Indolijohdannaisia NMDA-antagonisteina | |
| NO974043L (no) | Indolderivater som EAA-antagonister | |
| NO954287L (no) | Anvendelse av indolderivater som 5-HT1 agonister | |
| DE69506826D1 (de) | 5-HT4 Rezeptoragonisten | |
| DK0747346T3 (da) | N-acyl-2-arylcyclopropylmethylaminderivater som melatonerge midler | |
| DK1189583T3 (da) | Indolderivater | |
| NO985970L (no) | Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister | |
| IS6434A (is) | Nýjar indól afleiður | |
| NO20020306D0 (no) | Indolderivater | |
| NO985972L (no) | Indolinderivater anvendelige som 5-HT-2C reseptorantagonister | |
| DK1073651T3 (da) | Indolylderivater som serotonerge midler | |
| ATE193701T1 (de) | Substituierte indol-derivate | |
| DK0944601T3 (da) | Heterocykliske quanidinylaminoforbindelser som alfa-2-adrenoceptoragonister | |
| NO983656D0 (no) | Heterocyklyl-ergolinderivater som 5-HT1A reseptorligander |